DarioHealth has priced a $23.5 million registered direct offering of 3.45 million common shares at $6.80 per share. The offering includes the purchase of 14,430 common shares by a board member at $6.93 per share and is expected to close on July 23. Net proceeds will be used for working capital, investments, acquisitions, and general corporate purposes. The financing includes participation from existing long-term institutional investors and a new global fundamental institutional investor, with A.G.P./Alliance Global Partners serving as the sole placement agent.
DarioHealth CorpPriced a $23.5M direct offering at $6.80/share, diluting existing shareholders.